Literature DB >> 12063512

Overcoming barriers to nonadherence in asthma treatment.

Bruce G Bender1.   

Abstract

Inadequate patient adherence to prescribed treatment regimens is a major cause of poor clinical outcomes in the treatment of asthma. Among children with asthma, adherence rates are often below 50%. Multiple treatment-, clinician-, and patient-related barriers prevent the achievement of satisfactory levels of adherence. Treatment-related barriers include prolonged and complex regimens, adverse effects, cost, and delayed onset of action. Clinician-related barriers include difficulty in scheduling, treatment by one different care giver after another, perceived clinician disinterest, and time constraints. Patient-related barriers include mild or severe asthma, poor understanding of the need for treatment, insufficient confidence in the clinician or medication, the presence of psychological problems, and low motivation to change behavior. Although all of these factors must be addressed to maximize adherence, patient motivation may be the most critical. This task falls primarily to clinicians (physicians, nurses, staff), and it requires thorough patient and care giver education, more frequent patient contact, and the development of a patient-clinician partnership dedicated to the effective treatment of asthma.

Entities:  

Mesh:

Year:  2002        PMID: 12063512     DOI: 10.1067/mai.2002.124570

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  38 in total

Review 1.  Asthma adherence and the athlete.

Authors:  Ivan D Cardona; Christopher M Mjaanes; Jack M Becker
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

2.  The effects of barriers on Health Related Quality of Life (HRQL) and compliance in adult asthmatics who are followed in an urban community health care facility.

Authors:  Rosemary L Hoffmann; Wesley M Rohrer; Jeannette E South-Paul; Ray Burdett; Valerie J M Watzlaf
Journal:  J Community Health       Date:  2008-12

Review 3.  β(2) -adrenoceptor agonists: current and future direction.

Authors:  Mario Cazzola; Luigino Calzetta; Maria Gabriella Matera
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 4.  Intentional non-adherence to medications by older adults.

Authors:  Omar Mukhtar; John Weinman; Stephen H D Jackson
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

Review 5.  Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence.

Authors:  Henry Milgrom
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

6.  Assessing asthma severity among children and adults with current asthma.

Authors:  Hatice S Zahran; Cathy M Bailey; Xiaoting Qin; Jeanne E Moorman
Journal:  J Asthma       Date:  2014-03-06       Impact factor: 2.515

7.  The impact of parents' medication beliefs on asthma management.

Authors:  Kelly M Conn; Jill S Halterman; Kathleen Lynch; Michael D Cabana
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

Review 8.  Treatment of childhood asthma: how do the available options compare?

Authors:  David Coghlan; Colin Powell
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Management of exercise-induced bronchospasm in NCAA athletic programs.

Authors:  Jonathan P Parsons; Vincent Pestritto; Gary Phillips; Christopher Kaeding; Thomas M Best; Gail Wadley; John G Mastronarde
Journal:  Med Sci Sports Exerc       Date:  2009-04       Impact factor: 5.411

10.  Medication Identification Among Caregivers of Urban Children With Asthma.

Authors:  Sean M Frey; Maria Fagnano; Jill Halterman
Journal:  Acad Pediatr       Date:  2016-04-26       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.